ID   89MS30
AC   CVCL_G625
SY   GLXA-Ab1
DR   CLO; CLO_0001517
DR   ATCC; HB-11300
DR   Wikidata; Q54605479
RX   Patent=US5656271;
RX   PubMed=8837610;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11300.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Chlamydia trachomatis exoglycolipid antigen (GLXA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
RX   Patent=US5656271;
RA   MacDonald A.B., Whittum-Hudson J.A., Saltzman W.M.;
RT   "Oral vaccine comprising anti-idiotypic antibody to chlamydia
RT   glycolipid exoantigen and process.";
RL   Patent number US5656271, 12-Aug-1997.
//
RX   PubMed=8837610; DOI=10.1038/nm1096-1116;
RA   Whittum-Hudson J.A., An L.-L., Saltzman W.M., Prendergast R.A.,
RA   MacDonald A.B.;
RT   "Oral immunization with an anti-idiotypic antibody to the
RT   exoglycolipid antigen protects against experimental Chlamydia
RT   trachomatis infection.";
RL   Nat. Med. 2:1116-1121(1996).
//